http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-19713141-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1b9e7e6601477de52d0d3ece1739daad |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4045 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7061 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4045 |
| filingDate | 1997-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1997-10-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | DE-19713141-A1 |
| titleOfInvention | Transdermal system with melatonin |
| abstract | The transdermal system comprises a plaster consisting of a thin tear-off layer, an adhesive and a carrier layer. The adhesive layer contains a depot of melatonin which is present in an amount that gives a peak melatonin concentration in human blood some 1-5 hours after the plaster is removed. The plaster may also contain an oestrogen and/or a gestagen, as well as 0.1-10 % of additives such as softeners, viscosity stabilisers, crystallisation inhibitors, adhesion modulators and agents that enhance the uptake of moisture. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110022864-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110022864-B http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018080214-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2809618-A1 |
| priorityDate | 1996-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 39.